Health News
Date: Sep-02-2012
A study published in Current Biology details how an international team of researchers led by Monash University's Australian Regenerative Medicine Institute (ARMI) discovered the mechanism, which shuts down the signal triggering the body's initial inflammatory response to injury. When the body suffers a wound or abrasion, white blood cells, or leukocytes, travel to the site of the injury to protect the tissue from infection and start repairing the damage. However, this period of inflammation need only be temporary...
Date: Sep-02-2012
In a study published in the Journal of Neurology, researchers claim that because Attention Deficit Hyperactivity Disorder (ADHD), Fetal Alcohol Spectrum Disorder (FASD) and Parkinson's Disease (PD) each involve ocular control and attention dysfunctions, they can be easily identified through an evaluation of how patients move their eyes while they watch television. "Natural attention and eye movement behavior - like a drop of saliva - contains a biometric signature of an individual and her/his state of brain function or dysfunction," the article states...
Date: Sep-02-2012
A monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) and tested in an animal model at the Texas Biomedical Research Institute, prevents infection by the hepatitis C virus (HCV). Researchers found that the human monoclonal antibody targeting the virus protected chimpanzees from HCV infection in a dose-dependent manner in a study conducted at Texas Biomed's Southwest National Primate Research Center...
Date: Sep-02-2012
According to a study that will be published in Psychological Science, catastrophic events, for example, natural disasters, severe stock market dips, or terrorist attacks often happen more than once; twice, to be specific. Researchers say that the second event can cause just as much harm as the first, because it is usually due to our actions in response to the first event. The year after the horrific September 11th, 2001 terrorist attacks, around 1,600 more traffic deaths were prevalent than experts anticipated...
Date: Sep-02-2012
Soil bacteria and bacteria that cause human diseases have recently swapped at least seven antibiotic-resistance genes, researchers at Washington University School of Medicine in St. Louis report in Science. According to the scientists, more studies are needed to determine how widespread this sharing is and to what extent it makes disease-causing pathogens harder to control. "It is commonplace for antibiotics to make their way into the environment," says first author Kevin Forsberg, a graduate student...
Date: Sep-01-2012
Gruenenthal Group's CRO has apologized to mothers who took Thalidomide in the 1950s and 1960s and gave birth to children with congenital birth defects. Exactly 50 years ago today, Thalidomide was pulled off the market. In the 1950s and 1960s, Thalidomide was approved in 46 countries for the treatment of morning sickness during pregnancy, as well as aiding sleep. It was not sold in the USA. Thalidomide became extremely popular in Australia, West-Germany, and the United Kingdom. It was taken off the market in 1961 after it was found to be closely linked to birth defects...
Date: Sep-01-2012
May enhance evaluation of cancer risk in the up to 1.5 million women who receive an indeterminate Pap test result each year Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer...
Date: Sep-01-2012
Scientists at the University of Liverpool are leading a £1.65 million project to produce and test the first nanomedicines for treating HIV/AIDS. The research project, funded by the Engineering and Physical Sciences Research Council (EPSRC), aims to produce cheaper, more effective medicines which have fewer side effects and are easier to give to newborns and children. The new therapy options were generated by modifying existing HIV treatments, called antiretrovirals (ARVs)...
Date: Sep-01-2012
UH Pharmacologist Examines Age-related Oxidative, Inflammatory Stress with $1.5M NIH Grant Gaining new insight to managing sodium balance and blood pressure, investigators at the University of Houston (UH) College of Pharmacy believe their work may identify future therapeutic targets to control hypertension...
Date: Sep-01-2012
A new treatment from a University of Queensland start-up company, Spinifex Pharmaceuticals, could bring hope to shingles sufferers experiencing nerve pain. A recent clinical trial of the company's lead product, EMA401, showed promising results in treating the pain, medically known as postherpetic neuralgia (PHN). The results were presented at the 14th World Congress of Pain® in Milan, a major international meeting organised by the International Association for the Study of Pain (IASP®)...